Author:
Wilmanns W.,Wilms K.,Rajewsky M. F.,Klein H. O.,Lennartz K. J.,Hirschmann W. D.,Oerkermann H.,Gross R.,Freireich Emil J.,Bodey Gerald P.,Mccredie Kenneth B.,Hart Jacqueline S.,Whitecar John P.,Hersh Evan M.,Martin H.,Fischer M.,Schubert J. C. F.,Fülle H. H.,Pribilla W.,Lang H. D.,Wilmanns W.,Wilms K.,Riehm H.,Gadner H.,Jessenberger K.,Odenwald E.,Tariverdian G.,Vortisch M.,Stück B.,Simon A.,Obrecht P.,Hennekeuser H. H.,Westerhausen M.,Sodomann C.-P.,Malchow H.,Schmidt M.,Havemann K.,Brüster H.,Aust Christa,Boll Irene,Mathé G.,Schoen H. D.,Mayer G.,Mayer Simone,Kalogjera Vesna,Krepler P.,Biskamp K.,Schubert J. C. F.,Stille W.,Martin H.,Brücher H.,Kirstaedter H.-J.,Rühl H.,Dietrich M.,Fliedner T. M.,Kubanek B.,Heimpel H.,Scholz N.,Brittinger G.,Linzenmeier G.,Konig E.,Wendt F.,Mueller-Eckhardt Ch.,Kretschmer V.,Heinrich D.,Kwapisz A.,Adam W.,Marcard E.,Flad H.-D.
Publisher
Springer Berlin Heidelberg
Reference37 articles.
1. Bertino, J. R.: The mechanism of action of the folate antagonists in man. Cancer Res. 23, 1286 (1963).
2. Breitman, T. R.: The feed back inhibition of thymidine kinase. Biochim. biophys. Acta (Amst.) 67, 153 (1963).
3. Bresnick, E., Karjala, R. J.: End-product inhibition of thymidine kinase activity in normal and leucemic leucocytes. Cancer Res. 24, 841 (1964).
4. Chu, M. Y., Fischer, G. A.: A proposed mechanism of action of 1-fl-D-arabinofuranosylcytosine as an inhibitor of the growth of leukemic cells. Biochem. Pharmacol. 11, 423 (1962).
5. Di Marco, A., Gaetani, M., Scarpinato, B.: Adriamycin, a new antibiotic with antitumor activity. Cancer Chemother. Rept. 53, 33 (1969).